Bioblast Pharma Ltd Share Price Nasdaq
Equities
IL0011319527
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 30.48M 2.43B |
---|---|---|---|---|---|
Net income 2024 * | -16M -1.28B | Net income 2025 * | -12M -957M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.88
x | P/E ratio 2025 * |
-2.95
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.79% |
Managers | Title | Age | Since |
---|---|---|---|
Oren Hershkovitz
CEO | Chief Executive Officer | 47 | 15/11/19 |
Dror Mevorach
FOU | Founder | 68 | 31/12/08 |
Director of Finance/CFO | 47 | 31/12/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Shai Novik
CHM | Chairman | 58 | 25/03/19 |
Avri Havron
BRD | Director/Board Member | 76 | 31/12/13 |
Brian Schwartz
BRD | Director/Board Member | 52 | 30/11/20 |
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |